Alisha Armstrong
About Alisha Armstrong
Alisha Armstrong serves as the Director of Clinical Operations at BridgeBio, where she has worked since 2023. She has extensive experience in clinical research across various therapeutic areas and has held multiple roles in prominent organizations over her career.
Current Role at BridgeBio
Alisha Armstrong serves as the Director of Clinical Operations at BridgeBio, a position she has held since 2023. In this role, she oversees clinical operations, ensuring the effective execution of clinical trials. Her work is conducted remotely, allowing her to manage operations across various locations.
Previous Experience in Clinical Research
Prior to her current role, Alisha Armstrong accumulated extensive experience in clinical research. She worked at CombinatoRx as a Clinical Trial Coordinator II and later as a Clinical Research Associate. She also held positions at Abiomed, PPD, and IQVIA, where she advanced from Senior Clinical Research Associate to Associate Clinical Lead Director. Her diverse roles have equipped her with a comprehensive understanding of clinical trial management.
Education and Expertise
Alisha Armstrong holds a Bachelor of Science degree in Health and Human Services with a concentration in Clinical Research from the University of Massachusetts Amherst. She also has a Medical Assisting Degree from CEI. Additionally, she possesses an advanced degree in Public Health with a focus on Health & Human Services, enhancing her expertise in clinical operations.
Therapeutic Areas of Expertise
Alisha Armstrong has developed expertise in a wide range of therapeutic areas throughout her career. Her knowledge spans Cardiovascular Disease, Pediatrics, Renal, Endocrine, Dental, Infectious Disease, Central Nervous System, Rheumatology, Rare Disease, Oncology, and Regenerative Medicine. This broad expertise supports her ability to manage diverse clinical trials effectively.
Global Clinical Trial Experience
Alisha Armstrong has extensive experience in conducting clinical trials across multiple regions, including Asia-Pacific, EMEA, Latin America, Canada, and the USA. Her global perspective enhances her capability to navigate the complexities of international clinical research and regulatory environments.